Title: Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience.
Citation: J Asthma
2023;60:158–166.
Country: Italy | Indication: Asthma
http://tago.ca/35112934
Title: Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience.
Citation: J Asthma
2023;60:158–166.
Country: Italy | Indication: Asthma
Title: Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience.
Citation: J Asthma
2023;60:158–166.
Country: Italy | Indication: Asthma